EDOC


Telemedicine & Digital Health ETF

Reasons to Consider EDOC

High Growth Potential

We estimate the global digital health market to have increased 14% from 2022 to 2023.1 Our estimates show that, given growing adoption, the market could be worth nearly $450B by 2030.2

Leveraging Artificial Intelligence

AI could be the missing link to achieve transformative digitization in the Health Care sector. In the U.S. alone, it’s estimated that AI could save as much as 10% of annual health care spending.3

Expanding Use Cases

Following success in diabetic monitoring, wearables are expanding into other pockets of care, such as heart health. Nearly half of U.S. adults have some type of cardiovascular disease.4

1Global X Forecast as of June 30, 2024
2Ibid
3National Bureau of Economic Research, Jan 2023
4American Heart Association, 2024

Key Information As of 03/18/25

Inception Date 07/29/20
Total Expense Ratio 0.68%
Net Assets $35.50 million
NAV $9.83
Fact Sheet View the document

ETF Summary

The Global X Telemedicine & Digital Health ETF (EDOC) seeks to invest in companies positioned to benefit from further advances in the field of telemedicine and digital health. This includes companies involved in Telemedicine, Health Care Analytics, Connected Health Care Devices, and Administrative Digitization.

ETF Objective

The Global X Telemedicine & Digital Health ETF (EDOC) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Telemedicine & Digital Health Index.

Trading Details As of 03/18/25

Ticker EDOC
Bloomberg Index Ticker SOLEDOC
CUSIP 37954Y285
ISIN US37954Y2853
Primary Exchange Nasdaq
Shares Outstanding 3,610,000
Number of Holdings 39
30-Day Median Bid-Ask Spread 0.67%

Distributions As of 03/18/25

30-Day SEC Yield 0.25%
Distribution Frequency Semi-Annually

ETF Prices As of 03/18/25

NAV $9.83 Daily Change -$0.11 -1.11%
Market Price $9.77 Daily Change -$0.23 -2.30%

Performance History

As of recent
(12/31/24)
As of recent
(12/31/24)
Fund NAV Market Price Index
1 Year -2.66% -2.87% -2.00%
3 Years -15.77% -15.92% -15.40%
Since Inception -9.28% -9.41% -8.84%
1 Year 10.68% 10.30% 11.42%
3 Years -9.98% -10.08% -9.58%
Since Inception -7.64% -7.80% -7.19%
Year-to-Date -2.66% -2.87% -2.00%
1 Month -5.45% -6.20% -5.35%
3 Months -2.18% -1.90% -1.95%
Since Inception -35.04% -35.43% -33.60%
Year-to-Date 6.88% 6.71% 6.97%
1 Month -3.47% -4.11% -3.46%
3 Months 1.05% 0.10% 1.25%
Since Inception -30.57% -31.10% -28.98%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 03/18/25

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
5.98 DOCS DOXIMITY INC-CLASS A BMD22Y4 61.31 34,639 2,123,717.09
5.95 HIMS HIMS & HERS HEALTH INC BN46048 31.49 67,109 2,113,262.41
4.90 6618 HK JD HEALTH BMW8R04 4.47 389,800 1,740,984.91
4.88 241 HK ALIBABA HEALTH BRXVS60 0.71 2,430,900 1,733,407.04
4.80 PME AU PRO MEDICUS LTD 6292782 148.05 11,504 1,703,205.18
4.79 MASI MASIMO CORP B1YWR63 168.16 10,104 1,699,088.64
4.48 PODD INSULET CORP B1XGNW4 260.47 6,109 1,591,211.23
4.44 DGX QUEST DIAGNOSTICS INC 2702791 172.45 9,131 1,574,640.95
4.41 LH LABCORP HOLDINGS INC BSBK800 239.68 6,524 1,563,672.32
4.24 IRTC IRHYTHM TECHNOLOGIES INC BYT4ST5 101.66 14,817 1,506,296.22
3.94 DXCM DEXCOM INC B0796X4 70.70 19,793 1,399,365.10
3.75 RMD RESMED INC 2732903 220.25 6,043 1,330,970.75
3.74 A AGILENT TECHNOLOGIES INC 2520153 123.10 10,784 1,327,510.40
3.70 QGEN QIAGEN N.V. BS2CPH1 39.75 33,079 1,314,890.25
3.40 PRVA PRIVIA HEALTH GROUP INC BMDP209 23.62 51,069 1,206,249.78
3.34 IQV IQVIA HOLDINGS INC BDR73G1 188.54 6,280 1,184,031.20
3.21 VCYT VERACYTE INC BFTWZY0 31.24 36,450 1,138,698.00
3.09 TWST TWIST BIOSCIENCE CORP BGKG6G7 40.57 27,021 1,096,241.97
3.02 OSCR OSCAR HEALTH -A BKY83Q6 12.83 83,545 1,071,882.35
2.40 ILMN ILLUMINA INC 2613990 85.16 10,022 853,473.52
2.00 OMCL OMNICELL INC 2789523 32.93 21,608 711,551.44
2.00 PHR PHREESIA INC BKF9DQ8 27.27 25,984 708,583.68
1.92 TDOC TELADOC HEALTH INC BYQRFY1 8.39 81,163 680,957.57
1.77 TNDM TANDEM DIABETES CARE INC BF3W461 20.06 31,281 627,496.86
1.52 EVH EVOLENT HEALTH INC - A BYLY8H1 10.14 53,231 539,762.34
1.28 AMN AMN HEALTHCARE 2813552 24.97 18,156 453,355.32
1.01 LFST LIFESTANCE HEALT BN0TRB7 6.74 53,375 359,747.50
0.90 COP GR COMPUGROUP MEDIC BMY7CH1 24.89 12,814 318,963.81
0.78 1833 HK PING AN HEALTHCA BDRYVB3 0.99 279,200 277,072.54
0.63 4483 JP JMDC INC BK7C5Q9 19.74 11,298 223,072.86
0.60 4480 JP MEDLEY INC BK93ZN7 21.81 9,823 214,222.03
0.49 GDRX GOODRX HOLDIN-A BMTVQT8 4.48 38,945 174,473.60
0.47 TALK TALKSPACE INC BP7L970 2.73 61,352 167,490.96
0.46 FLGT FULGENT GENETICS INC BYQBFQ5 17.13 9,458 162,015.54
0.43 PACB PACIFIC BIOSCIEN B4N8MH9 1.22 124,408 151,777.76
0.39 LFMD LIFEMD INC BMXDBQ2 5.65 24,299 137,289.35
0.32 DCGO DOCGO INC BKP4P23 2.84 39,895 113,301.80
0.30 228760 KS GENOMICTREE INC BYNNYF6 12.03 8,893 106,996.35
0.19 DH DEFINITIVE HEALT BMGSDK2 2.77 24,805 68,709.85
0.03 OTHER PAYABLE & RECEIVABLES 1.00 12,013 12,012.71
0.03 KOREAN WON 0.00 15,665,857 10,782.85
0.02 CASH 1.00 8,209 8,209.33
0.00 HONG KONG DOLLAR 0.13 4 0.51
0.00 TAIWAN DOLLAR 0.03 1 0.03
Holdings are subject to change. "Cash" denotes U.S. dollars.

Exposure As of 02/28/25

Sector Weight (%)
Health Care 92.4
Materials 4.1
Financials 3.2
Energy 0.3

Source: new windowAltaVista Research, LLC

Industry Weight (%)
Health Care Equipment & Services 67.5
Pharmaceuticals, Biotechnology & Life Sciences 19.0
Health Care Equipment & Servic 6.0
Materials 4.1
Insurance 3.2
Energy 0.3

Source: new windowAltaVista Research, LLC

Country Weight (%)
United States 79.9
China 5.3
Australia 4.9
Hong Kong 4.2
Netherlands 3.5
Japan 1.1
Germany 0.8
South Korea 0.3

Source: new windowAltaVista Research, LLC

All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.

ETF Characteristics As of 03/18/25

Return on Equity 6.90%
Weighted Avg. Market Cap 13,042 M
2024 2025
Price-to-earnings 1,950.27 46.16
Price-to-book value 3.29 3.10

Source: new windowAltaVista Research, LLC

ETF Risk Stats As of 02/28/25

Versus Beta
S&P 500 1.18
NASDAQ-100 0.84
MSCI EAFE 1.12
MSCI Emg. Mkts 0.92
Standard Deviation 25.80%

Source: new windowAltaVista Research, LLC

ETF Research

View More Related Research

Investing involves risk, including the possible loss of principal. The investable universe of companies in which EDOC may invest may be limited. The Fund invests in securities of companies engaged in the Health Care and Information Technology sectors. These sectors can be affected by government regulations, rapid product obsolescence, intense industry competition and loss or impairment of patents or intellectual property rights. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. EDOC is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Solactive AG, nor does Solactive AG make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Solactive AG.